Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

SELL
$4.41 - $5.69 $70,110 - $90,459
-15,898 Reduced 1.07%
1,466,538 $7.76 Million
Q1 2022

Apr 27, 2022

BUY
$4.81 - $6.99 $806,064 - $1.17 Million
167,581 Added 12.75%
1,482,436 $8.14 Million
Q4 2021

Jan 31, 2022

BUY
$5.97 - $7.93 $221,128 - $293,727
37,040 Added 2.9%
1,314,855 $8.95 Million
Q3 2021

Nov 02, 2021

SELL
$4.79 - $6.68 $1.21 Million - $1.68 Million
-252,211 Reduced 16.48%
1,277,815 $7.78 Million
Q2 2021

Aug 03, 2021

BUY
$5.35 - $6.35 $345,786 - $410,419
64,633 Added 4.41%
1,530,026 $9.04 Million
Q1 2021

May 11, 2021

BUY
$5.68 - $7.87 $695,550 - $963,728
122,456 Added 9.12%
1,465,393 $8.81 Million
Q4 2020

Jan 19, 2021

SELL
$5.25 - $8.56 $1.21 Million - $1.98 Million
-230,835 Reduced 14.67%
1,342,937 $9.29 Million
Q3 2020

Oct 20, 2020

BUY
$5.78 - $7.47 $777,785 - $1.01 Million
134,565 Added 9.35%
1,573,772 $9.85 Million
Q2 2020

Jul 30, 2020

SELL
$4.5 - $7.02 $1.35 Million - $2.11 Million
-300,630 Reduced 17.28%
1,439,207 $9.5 Million
Q1 2020

Apr 17, 2020

SELL
$2.87 - $5.49 $1.84 Million - $3.53 Million
-642,829 Reduced 26.98%
1,739,837 $8.09 Million
Q4 2019

Jan 16, 2020

BUY
$3.84 - $4.86 $1.36 Million - $1.73 Million
355,211 Added 17.52%
2,382,666 $10.1 Million
Q3 2019

Oct 16, 2019

SELL
$4.86 - $6.05 $812,460 - $1.01 Million
-167,173 Reduced 7.62%
2,027,455 $10.5 Million
Q2 2019

Jul 18, 2019

BUY
$4.51 - $6.6 $1.17 Million - $1.72 Million
259,932 Added 13.44%
2,194,628 $0
Q1 2019

Apr 12, 2019

SELL
$5.16 - $6.85 $1.08 Million - $1.43 Million
-208,629 Reduced 9.73%
1,934,696 $0
Q4 2018

Jan 17, 2019

BUY
$4.89 - $7.16 $2.32 Million - $3.39 Million
474,106 Added 28.4%
2,143,325 $10.9 Million
Q3 2018

Oct 18, 2018

SELL
$6.89 - $7.78 $2.32 Million - $2.62 Million
-336,346 Reduced 16.77%
1,669,219 $0
Q2 2018

Jul 12, 2018

SELL
$5.19 - $7.25 $625,851 - $874,263
-120,588 Reduced 5.67%
2,005,565 $0
Q1 2018

Apr 16, 2018

SELL
$3.56 - $5.74 $2.54 Million - $4.1 Million
-714,351 Reduced 25.15%
2,126,153 $0
Q4 2017

Jan 24, 2018

BUY
$2.76 - $3.95 $67,655 - $96,826
24,513 Added 0.87%
2,840,504 $0
Q3 2017

Oct 25, 2017

BUY
$2.22 - $2.73 $6.25 Million - $7.69 Million
2,815,991
2,815,991 $0

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $303M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Peregrine Capital Management LLC Portfolio

Follow Peregrine Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.